View in EDS HTML Full Text PDF Full Text

From immunomodulators (IMiDs) to cereblon E3 ligase modulator (CELMoDs): the evolution of cereblon modulators in lymphoma therapy.

Saved in:
Bibliographic Details
Title: From immunomodulators (IMiDs) to cereblon E3 ligase modulator (CELMoDs): the evolution of cereblon modulators in lymphoma therapy.
Authors: Saha, Aditi1 (AUTHOR), Jhaveri, Khushali2 (AUTHOR), Perini, Guilherme F.3 (AUTHOR), Chavez, Julio C.4 (AUTHOR) chavez.julio@mayo.edu
Source: Leukemia & Lymphoma. Jun2026, Vol. 67 Issue 7, p1479-1491. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2026.2662494